{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:29:24Z","timestamp":1788553764774,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"DOI":"10.7759\/cureus.78576","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T20:10:41Z","timestamp":1738786241000},"source":"Crossref","is-referenced-by-count":3,"title":["Primary Erythromelalgia: Historical Perspective and Current Update"],"prefix":"10.7759","author":[{"given":"Allison C","family":"Eaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey N","family":"Mayrovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000162","article-title":"Erythromelalgia: incidence and clinical experience in a single centre in Sweden","volume":"41","author":"Alhadad A","year":"2012","unstructured":"Alhadad A, Wollmer P, Svensson A, Eriksson KF. Erythromelalgia: incidence and clinical experience in a single centre in Sweden. Vasa. 2012, 41:43-8. 10.1024\/0301-1526\/a000162","journal-title":"Vasa"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0347-1","article-title":"Primary erythromelalgia: a review","volume":"10","author":"Tang Z","year":"2015","unstructured":"Tang Z, Chen Z, Tang B, Jiang H. Primary erythromelalgia: a review. Orphanet J Rare Dis. 2015, 10:127. 10.1186\/s13023-015-0347-1","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000675","article-title":"Erythromelalgia","volume":"47","author":"Klein-Weigel PF","year":"2018","unstructured":"Klein-Weigel PF, Volz TS, Richter JG. Erythromelalgia. Vasa. 2018, 47:91-7. 10.1024\/0301-1526\/a000675","journal-title":"Vasa"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.071","article-title":"Erythromelalgia. Part I: pathogenesis, clinical features, evaluation, and complications","volume":"90","author":"Caldito EG","year":"2024","unstructured":"Caldito EG, Kaul S, Caldito NG, Piette W, Mehta S. Erythromelalgia. Part I: pathogenesis, clinical features, evaluation, and complications. J Am Acad Dermatol. 2024, 90:453-62. 10.1016\/j.jaad.2023.02.071","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(38)90693-3","article-title":"Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat, and pain","volume":"16","author":"Smith LA","year":"1938","unstructured":"Smith LA, Allen EV. Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat, and pain. Am Heart J. 1938, 16:175-88. 10.1016\/S0002-8703(38)90693-3","journal-title":"Am Heart J"},{"key":"ref6","article-title":"On a rare vaso-motor neurosis of the extremities, and on the maladies with which it may be confounded","volume":"76","author":"Mitchell SW","year":"1878","unstructured":"Mitchell SW. On a rare vaso-motor neurosis of the extremities, and on the maladies with which it may be confounded. Am J Med Sci. 1878, 76:17-36.","journal-title":"Am J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02938","article-title":"Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota","volume":"23","author":"Reed KB","year":"2009","unstructured":"Reed KB, Davis MD. Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota. J Eur Acad Dermatol Venereol. 2009, 23:13-5. 10.1111\/j.1468-3083.2008.02938","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.29.1.136","article-title":"Erythermalgia. Review of 51 cases","volume":"29","author":"Babb RR","year":"1964","unstructured":"Babb RR, Alarcon-Segovia D, Fairbairn JF 2nd. Erythermalgia. Review of 51 cases. Circulation. 1964, 29:136-41. 10.1161\/01.cir.29.1.136","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang Y","year":"2004","unstructured":"Yang Y, Wang Y, Li S, et al.. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004, 41:171-4. 10.1136\/jmg.2003.012153","journal-title":"J Med Genet"},{"key":"ref10","article-title":"Clinical lectures on the practice of medicine","author":"Graves RJ","year":"1834","unstructured":"Graves RJ. Clinical lectures on the practice of medicine. Frannin and Co, Dublin, Ireland; 1834."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/320107","article-title":"The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32","volume":"68","author":"Drenth JP","year":"2001","unstructured":"Drenth JP, Finley WH, Breedveld GJ, et al.. The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32. Am J Hum Genet. 2001, 68:1277-82. 10.1086\/320107","journal-title":"Am J Hum Genet"},{"key":"ref12","article-title":"Clinical observations and experiments relating to burning pain in the extremities, and to so-called \u201cerythromelalgia\u201d in particular","volume":"1","author":"Lewis T","year":"1933","unstructured":"Lewis T. Clinical observations and experiments relating to burning pain in the extremities, and to so-called \u201cerythromelalgia\u201d in particular. Clin Sci. 1933, 1:175-211.","journal-title":"Clin Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-006-0008-8","article-title":"Erythromelalgia","volume":"8","author":"Davis MD","year":"2006","unstructured":"Davis MD, Rooke T. Erythromelalgia. Curr Treat Options Cardiovasc Med. 2006, 8:153-65. 10.1007\/s11936-006-0008-8","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.02.021","article-title":"Immersion foot associated with the overuse of ice, cold water, and fans: a distinctive clinical presentation complicating the syndrome of erythromelalgia","volume":"69","author":"Davis MD","year":"2013","unstructured":"Davis MD. Immersion foot associated with the overuse of ice, cold water, and fans: a distinctive clinical presentation complicating the syndrome of erythromelalgia. J Am Acad Dermatol. 2013, 69:169-71. 10.1016\/j.jaad.2013.02.021","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.2203.662","article-title":"The morbid anatomy of erythromelalgia based upon the examination of the amputated extremities of three cases","volume":"1","author":"Shaw HB","year":"1903","unstructured":"Shaw HB. The morbid anatomy of erythromelalgia based upon the examination of the amputated extremities of three cases. Br Med J. 1903, 1:662-3. 10.1136\/bmj.1.2203.662","journal-title":"Br Med J"},{"key":"ref16","article-title":"Some notes on a case of erythromelalgia; with treatment","volume":"85","author":"Voorhees IW","year":"1904","unstructured":"Voorhees IW. Some notes on a case of erythromelalgia; with treatment. Medical News (1882-1905). 1904, 85:737.","journal-title":"Medical News (1882-1905)"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1097\/00000372-199602000-00005","article-title":"Cutaneous pathology in primary erythermalgia","volume":"18","author":"Drenth JP","year":"1996","unstructured":"Drenth JP, Vuzevski V, Van Joost T, Daele MC, Vermylen J, Michiels JJ. Cutaneous pathology in primary erythermalgia. Am J Dermatopathol. 1996, 18:30-4.","journal-title":"Am J Dermatopathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1999.00510.x","article-title":"Skin perfusion in patients with erythromelalgia","volume":"29","author":"Littleford RC","year":"1999","unstructured":"Littleford RC, Khan F, Belch JJ. Skin perfusion in patients with erythromelalgia. Eur J Clin Invest. 1999, 29:588-93. 10.1046\/j.1365-2362.1999.00510.x","journal-title":"Eur J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1997.00185.x","article-title":"Erythromelalgia: a clinical study of 87 cases","volume":"242","author":"Kalgaard OM","year":"1997","unstructured":"Kalgaard OM, Seem E, Kvernebo K. Erythromelalgia: a clinical study of 87 cases. J Intern Med. 1997, 242:191-7. 10.1046\/j.1365-2796.1997.00185.x","journal-title":"J Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.8.1085","article-title":"Between episodes of erythromelalgia: a spectrum of colors","volume":"142","author":"Davis MD","year":"2006","unstructured":"Davis MD, Wilkins F, Rooke TW. Between episodes of erythromelalgia: a spectrum of colors. Arch Dermatol. 2006, 142:1085-6. 10.1001\/archderm.142.8.1085","journal-title":"Arch Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00944.x","article-title":"Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia","volume":"114","author":"M\u00f8rk C","year":"2000","unstructured":"M\u00f8rk C, Asker CL, Salerud EG, Kvernebo K. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol. 2000, 114:643-6. 10.1046\/j.1523-1747.2000.00944.x","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00131402-199912000-00001","article-title":"Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis","volume":"1","author":"Sandroni P","year":"1999","unstructured":"Sandroni P, Davis MD, Harper CM, et al.. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromuscul Dis. 1999, 1:57-63. 10.1097\/00131402-199912000-00001","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01726.x","article-title":"Impaired neurogenic control of skin perfusion in erythromelalgia","volume":"118","author":"M\u00f8rk C","year":"2002","unstructured":"M\u00f8rk C, Kalgaard OM, Kvernebo K. Impaired neurogenic control of skin perfusion in erythromelalgia. J Invest Dermatol. 2002, 118:699-703. 10.1046\/j.1523-1747.2002.01726.x","journal-title":"J Invest Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1042\/cs0960507","article-title":"Impaired skin vasomotor reflexes in patients with erythromelalgia","volume":"96","author":"Littleford RC","year":"1999","unstructured":"Littleford RC, Khan F, Belch JJ. Impaired skin vasomotor reflexes in patients with erythromelalgia. Clin Sci (Lond). 1999, 96:507-12. 10.1042\/cs0960507","journal-title":"Clin Sci (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23737.x","article-title":"SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels","volume":"124","author":"Drenth JP","year":"2005","unstructured":"Drenth JP, te Morsche RH, Guillet G, Taieb A, Kirby RL, Jansen JB. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol. 2005, 124:1333-8. 10.1111\/j.0022-202X.2005.23737.x","journal-title":"J Invest Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.10.1587","article-title":"Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7","volume":"62","author":"Michiels JJ","year":"2005","unstructured":"Michiels JJ, te Morsche RH, Jansen JB, Drenth JP. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. Arch Neurol. 2005, 62:1587-90. 10.1001\/archneur.62.10.1587","journal-title":"Arch Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13891","article-title":"Review of primary and secondary erythromelalgia","volume":"44","author":"Mann N","year":"2019","unstructured":"Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol. 2019, 44:477-82. 10.1111\/ced.13891","journal-title":"Clin Exp Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X11422584","article-title":"Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation","volume":"17","author":"Skeik N","year":"2012","unstructured":"Skeik N, Rooke TW, Davis MD, Davis DM, Kalsi H, Kurth I, Richardson RC. Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation. Vasc Med. 2012, 17:44-9. 10.1177\/1358863X11422584","journal-title":"Vasc Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.070","article-title":"Erythromelalgia. Part II: differential diagnoses and management","volume":"90","author":"Caldito EG","year":"2024","unstructured":"Caldito EG, Caldito NG, Kaul S, Piette W, Mehta S. Erythromelalgia. Part II: differential diagnoses and management. J Am Acad Dermatol. 2024, 90:465-74. 10.1016\/j.jaad.2023.02.070","journal-title":"J Am Acad Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2022.08.005","article-title":"Erythromelalgia: a review of medical management options and our approach to management","volume":"98","author":"Ma JE","year":"2023","unstructured":"Ma JE, Lee JU, Sartori-Valinotti JC, Rooke TW, Sandroni P, Davis MD. Erythromelalgia: a review of medical management options and our approach to management. Mayo Clin Proc. 2023, 98:136-49. 10.1016\/j.mayocp.2022.08.005","journal-title":"Mayo Clin Proc"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.09.008","article-title":"Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker","volume":"153","author":"Goldberg YP","year":"2012","unstructured":"Goldberg YP, Price N, Namdari R, et al.. Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker. Pain. 2012, 153:80-5. 10.1016\/j.pain.2011.09.008","journal-title":"Pain"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-021-00678-0","article-title":"Population pharmacokinetics of vixotrigine in healthy volunteers and subjects with trigeminal neuralgia, painful lumbosacral radiculopathy and erythromelalgia","volume":"46","author":"Naik H","year":"2021","unstructured":"Naik H, Zhao Y, Forrestal F, Cleall S, Bockbrader H, Chapel S. Population pharmacokinetics of vixotrigine in healthy volunteers and subjects with trigeminal neuralgia, painful lumbosacral radiculopathy and erythromelalgia. Eur J Drug Metab Pharmacokinet. 2021, 46:395-404. 10.1007\/s13318-021-00678-0","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317851-primary-erythromelalgia-historical-perspective-and-current-update","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T20:10:45Z","timestamp":1738786245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317851-primary-erythromelalgia-historical-perspective-and-current-update"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.78576","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}